Speaker illustration

Doctor Ana Sofia Martinho

University Hospitals of Coimbra, Coimbra (Portugal)

Member of:

European Society of Cardiology
Heart Failure Association

Ventricular tachycardia ablation before an implantable cardioverter defibrillator in secondary prevention: is always the best option?

Event: ESC Congress 2022

Topic: Device Treatment

Session: Device treatment of arrhythmias

Thumbnail

Prognostic nutritional index: an undervalued and underused prognostic marker in acute heart failure patients

Event: Heart Failure 2022

Topic: Comorbidities

Session: Heart Failure ePosters - focus on Chronic Heart Failure 4

Thumbnail

Malnutrition: a mascaraed and underused prognostic marker in coronary patients

Event: ACNAP-EuroHeartCare 2022

Topic: Treatment

Session: ePoster session 1

Thumbnail

Usefulness of the physiological single chamber pacemaker VDD in elderly patients with normal sinus rhythm

Event: EHRA 2022

Topic: Antibradycardia Pacing

Session: ePosters Day 3

Thumbnail

Ten years of experience in pre-transplant patients from an advanced heart failure center - when is the best time to step in?

Event: ESC Acute CardioVascular Care 2022

Topic: Epidemiology, Prognosis, Outcome

Session: e-Posters session

Thumbnail

Ten years of experience in pre-transplant patients from an advanced heart failure center - when is the best time to step in?

Event: ESC Acute CardioVascular Care 2022

Topic: Acute Heart Failure

Session: Best ePoster in Acute heart failure – Epidemiology and outcome

Thumbnail

Strauss formula: a great and easy tool to manage congestion in acute heart failure

Event: ESC CONGRESS 2020 - The Digital Experience

Topic: Biomarkers

Session: What’s New in the Diagnostics of Acute Heart Failure: Imaging Tools and Biomarkers

Thumbnail

Left ventricular reverse remodeling and angiotensin ii receptor blocker neprilysin inhibitor - a real-world data

Event: EuroEcho 2019

Topic: Echocardiography, Other

Session: Imaging: miscellaneous

Thumbnail

Real-world experience with angiotensin ii receptor blocker neprilysin inhibitor: reverse remodelling is the norm

Event: Heart Failure 2019 - 6th World Congress on Acute Heart Failure

Topic: Heart Failure with Reduced Ejection Fraction (HFrEF)

Session: Chronic Heart Failure – Pathophysiology and Mechanisms

Thumbnail

This platform is supported by

logo Novo Nordisk